MicroRNA-29a-5p Is a Novel Predictor for Early Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma after Surgical Resection

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Zhu, Hai Tao ^a,b   Dong, Qiong Zhu ^a,b   Sheng, Yuan Yuan ^a,b   Wei, Jin Wang ^a,b   Wang, Guan ^a,b   Zhou, Hai Jun ^a,b   Ren, Ning ^a,b   Jia, Hu Liang ^a,b   Ye, Qing Hai ^a,b   Qin, Lun Xiu ^a,b  

^a FUDAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 29A 5P; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER TISSUE; CONTROLLED STUDY; FEMALE; HEPATITIS B VIRUS RELATED LIVER CELL CARCINOMA; HUMAN; HUMAN TISSUE; LIVER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS B VIRUS; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICRODISSECTION; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; ROC CURVE; TIME FACTORS;

HEPATITIS B VIRUS;

EID: 84871416444     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052393     Document Type: Article

References (48)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Livraghi T, Makisalo H, Line PD, (2011) Treatment options in hepatocellular carcinoma today. Scand J Surg 100: 22-29.
3. Llovet JM, Schwartz M, Mazzaferro V, (2005) Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 25: 181-200.
4. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, et al. (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38: 200-207.
5. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
6. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs- microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
7. Patterson EE, Holloway AK, Weng J, Fojo T, Kebebew E, (2011) MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy. Cancer 117: 1630-1639.
8. Yip L, Kelly L, Shuai Y, Armstrong MJ, Nikiforov YE, et al. (2011) MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma. Ann Surg Oncol 18: 2035-2041.
9. Xi Y, Nakajima G, Gavin E, Morris CG, Kudo K, et al. (2007) Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA 13: 1668-1674.
10. Siebolts U, Varnholt H, Drebber U, Dienes HP, Wickenhauser C, et al. (2009) Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR. J Clin Pathol 62: 84-88.
11. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, et al. (1996) Laser capture microdissection. Science 274: 998-1001.
12. Duncavage E, Goodgame B, Sezhiyan A, Govindan R, Pfeifer J, (2010) Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer. J Thorac Oncol 5: 1755-1763.
13. Patnaik SK, Kannisto E, Knudsen S, Yendamuri S, (2010) Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res 70: 36-45.
14. Chung GE, Yoon JH, Myung SJ, Lee JH, Lee SH, et al. (2010) High expression of microRNA-15b predicts a low risk of tumor recurrence following curative resection of hepatocellular carcinoma. Oncol Rep 23: 113-119.
15. Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, et al. (2008) Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 47: 897-907.
16. Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, et al. (2005) Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan. Am J Gastroenterol 100: 1764-1771.
17. Sun HC, Zhang W, Qin LX, Zhang BH, Ye QH, et al. (2007) Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. J Hepatol 47: 684-690.
18. Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, et al. (2008) Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 100: 698-711.
19. Haller F, Kulle B, Schwager S, Gunawan B, von Heydebreck A, et al. (2004) Equivalence test in quantitative reverse transcription polymerase chain reaction: confirmation of reference genes suitable for normalization. Anal Biochem 335: 1-9.
20. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, et al. (2009) A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 10: R64.
21. Lan FF, Wang H, Chen YC, Chan CY, Ng SS, et al. (2010) Hsa-let-7g inhibits proliferation of hepatocellular carcinoma Cells by down-regulation of c-Myc and Up-regulation of p16(INK4A). Int J Cancer.
22. Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, et al. (2010) MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 70: 5184-5193.
23. Ji J, Zhao L, Budhu A, Forgues M, Jia HL, et al. (2010) Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J Hepatol 52: 690-697.
24. Ding J, Huang S, Wu S, Zhao Y, Liang L, et al. (2010) Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol 12: 390-399.
25. Wang Y, Lee AT, Ma JZ, Wang J, Ren J, et al. (2008) Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J Biol Chem 283: 13205-13215.
26. Peltier HJ, Latham GJ, (2008) Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14: 844-852.
27. Ura S, Honda M, Yamashita T, Ueda T, Takatori H, et al. (2009) Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 49: 1098-1112.
28. Kurokawa Y, Matoba R, Takemasa I, Nagano H, Dono K, et al. (2004) Molecular-based prediction of early recurrence in hepatocellular carcinoma. J Hepatol 41: 284-291.
29. Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, et al. (2006) Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 243: 229-235.
30. Nakashima Y, Nakashima O, Tanaka M, Okuda K, Nakashima M, et al. (2003) Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res 26: 142-147.
31. Sherman M, (2008) Recurrence of hepatocellular carcinoma. N Engl J Med 359: 2045-2047.
32. Van Deusen MA, Abdalla EK, Vauthey JN, Roh MS, (2005) Staging classifications for hepatocellular carcinoma. Expert Rev Mol Diagn 5: 377-383.
33. Villanueva A, Hoshida Y, Battiston C, Tovar V, Sia D, et al. (2011) Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology 140: 1501-1512 e1502.
34. Bruix J, Llovet JM, (2009) Major achievements in hepatocellular carcinoma. Lancet 373: 614-616.
35. Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, et al. (2004) Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 40: 667-676.
36. Iizuka N, Oka M, Yamada-Okabe H, Nishida M, Maeda Y, et al. (2003) Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet 361: 923-929.
37. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, et al. (2008) Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 359: 1995-2004.
38. Zhou H, Huang H, Shi J, Zhao Y, Dong Q, et al. (2010) Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection. Gut 59: 1699-1708.
39. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
40. Hudson RS, Yi M, Esposito D, Watkins SK, Hurwitz AA, et al. (2011) MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. Nucleic Acids Res 40: 3689-3703.
41. Du ZM, Hu LF, Wang HY, Yan LX, Zeng YX, et al. (2011) Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A. PLoS One 6: e19137.
42. Yoon SO, Chun SM, Han EH, Choi J, Jang SJ, et al. (2011) Deregulated expression of microRNA-221 with the potential for prognostic biomarkers in surgically resected hepatocellular carcinoma. Hum Pathol 42: 1391-1400.
43. Spahn M, Kneitz S, Scholz CJ, Stenger N, Rudiger T, et al. (2010) Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. Int J Cancer 127: 394-403.
44. Wang LG, Gu J, (2012) Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. Cancer Epidemiol 36: e61-67.
45. Plaisier CL, Pan M, Baliga NS, (2012) A miRNA-regulatory network explains how dysregulated miRNAs perturb oncogenic processes across diverse cancers. Genome Res 22: 2302-2314.
46. Xiong Y, Fang JH, Yun JP, Yang J, Zhang Y, et al. (2010) Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 51: 836-845.
47. Braconi C, Kogure T, Valeri N, Huang N, Nuovo G, et al. (2011) microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 30: 4750-4756.
48. Kong G, Zhang J, Zhang S, Shan C, Ye L, et al. (2011) Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS One 6: e19518.